Literature DB >> 25027818

Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.

Meric Karacan1, Melike Batukan, Ziya Cebi, Munip Berberoglugil, Semra Levent, Mustafa Kır, Alpaslan Baksu, Emine Ozel, Teksen Camlıbel.   

Abstract

PURPOSE: To determine the prevalence of acute cytomegalovirus (CMV), rubella and T. gondii infections among pregnant women who had no serological status tested for these microorganisms prior to pregnancy in a metropolitan area.
METHODS: A cross-sectional study was undertaken between January 2009 and January 2013 in 1,258 women presenting for their first antenatal visit (between 6 and 11 weeks of gestation). All women were tested for IgG and IgM antibodies. Subsequently, avidity test was utilized for inconclusive results. They were followed until delivery and all newborns were examined by a pediatrician.
RESULTS: Presence of IgM antibody positivity alone was not detected in any women. Avidity test excluded primary infection in 15 out of 16 (93.7 %) women who were positive for both IgG and IgM antibodies. Amniocentesis was performed in one case with borderline IgG avidity for T. gondii. No primary infections were detected in any newborn for the infections screened. The prevalences of IgG antibodies were 95 % for rubella, 84.1 % for CMV and 23.1 % for T. gondii.
CONCLUSIONS: Assessment of IgG and IgM antibodies followed by IgG avidity testing for inconclusive results may be an acceptable approach in pregnant women with unknown serological status prior to pregnancy. Utilization of IgG avidity as a supplemental test prevented unnecessary intervention in IgG and IgM antibodies positive patients. No primary infection was detected for CMV, rubella and T. gondii infections in the urban population screened.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027818     DOI: 10.1007/s00404-014-3340-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

Review 1.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

Review 2.  Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-18       Impact factor: 3.267

3.  TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals.

Authors:  Onur Numan; Fisun Vural; Nurettin Aka; Murat Alpay; Ayse Deniz Erturk Coskun
Journal:  North Clin Istanb       Date:  2015-12-25

4.  Seroprevalence of Toxoplasma, Rubella, and Cytomegalovirus among pregnant women in Van.

Authors:  Mehmet Parlak; Numan Çim; Begüm Nalça Erdin; Ayşe Güven; Yasemin Bayram; Recep Yıldızhan
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

5.  The seroprevalence of Rubella in pregnant women in Turkey: a meta-analysis research of 90988 Rubella IgM, 84398 Rubella IgG, and 522 avidity results.

Authors:  Rıza Aytaç Çetinkaya; Ercan Yenilmez
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

6.  Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region.

Authors:  Sangeeta Deka; Deepjyoti Kalita; Manisha Paul; Gaurav Badoni; Yogendra P Mathuria
Journal:  Cureus       Date:  2022-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.